Obesity Drug Gets Green Light From FDA Advisory Panel
Links shared publicly online about this topic
Obesity Drug, Contrave Gets Green Light From FDA Advisory Panel
medicalnewstoday.com — “Experimental drug Contrave(R) (naltrexone SR/bupropion SR) for the treatment of obesity has been recommended for approval by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee. The Co” View full resource at medicalnewstoday.com
Most Recently Shared on December 8, 2010 at 6:01 pm By:
Obesity Drug, Contrave Gets Green Light From FDA Advisory Panel Experimental drug Contrave(R) (naltrexone SR/bupropion .. http://dld.bz/9Ufx
Firazyr For Hereditary Angioedema Gets Green Light From FDA Advisory Panel
medicalnewstoday.com — “An FDA Pulmonary-Allergy Drugs Advisory Committee voted in favor 11 to 1 (one abstention) of approving Firazyr (22150, icatibant solution), a medication for the treatment of hereditary angioedema” View full resource at medicalnewstoday.com
Most Recently Shared on June 25, 2011 at 1:05 am By:
MNT Drug Approvals Health News
Firazyr For Hereditary Angioedema Gets Green Light From FDA Advisory Panel http://mnt.to/3XFh #regulatory
Epilepsy Drug Ezogabine Gets Green Light From FDA Advisory Panel - QualityPoint Technologies
qualitypointtech.net — “Ezogabine (Potiga) won a hearty endorsement by the FDA's Peripheral and Central Nervous System Drugs Advisory Committee for its efficacy as adjunctive treatment in partial-onset seizures. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on August 12, 2010 at 4:48 pm By:
Epilepsy Drug Ezogabine Gets Green Light From FDA Advisory Panel: Ezogabine (Potiga) won a hearty endorsement by t... http://bit.ly/cmqsKR
Firazyr For Hereditary Angioedema Gets Green Light From FDA Advisory Panel - QualityPoint Technologies
qualitypointtech.net — “An FDA Pulmonary-Allergy Drugs Advisory Committee voted in favor 11 to 1 (one abstention) of approving Firazyr (22150, icatibant solution), a medication for the treatment of hereditary angioedema in patients aged 18+ years. Although the Committee's recommendations are not binding, the FDA nearly always goes along with what the Panel (Committee) advice. The FDA is expected to make its final decision on 25th August, 2011...” View full resource at qualitypointtech.net
Most Recently Shared on June 25, 2011 at 2:45 am By:
Firazyr For Hereditary Angioedema Gets Green Light From FDA Advisory Panel: An FDA Pulmonary-Allergy Drugs Advisor... http://bit.ly/jdrn0l
Seattle Genetics Lymphoma Drug Gets Second Green Light from FDA Panel | Xconomy
xconomy.com — “Seattle Genetics batted a clean 2-for-2 today in its appearances in front of an FDA advisory committee. The FDA's Oncologic Drugs Advisory Committee voted” View full resource at xconomy.com
Most Recently Shared on July 14, 2011 at 7:50 pm By:
Luke Timmerman Health Communicator
Seattle Genetics gets 2nd green light from FDA panel for lymphoma drug. http://bit.ly/pTnPbZ
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
medical_tweets
-
MNT Drug Approvals
The latest regulatory affairs / drug approvals news published daily. Articles from research centers, universities and prestigious journals.
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
Advertisement
